Which dose of steroids and which cytotoxics for severe lupus?
- PMID: 24882275
- DOI: 10.1016/j.lpm.2014.03.001
Which dose of steroids and which cytotoxics for severe lupus?
Abstract
There have been a number of major advances in the treatment of systemic lupus erythematosus and we are now in the era of biologic therapies for this multisystem autoimmune disorder. There has been a greater awareness of the toxicities of the traditional therapies including the recognition that the doses of corticosteroids used in the past have been excessive, resulting in unacceptable toxicities. Other advances have included the development of lower cumulative doses of cyclophosphamide and the widespread acceptance of mycophenolate mofetil for the treatment of lupus nephritis. This review addresses the current management of severe lupus with corticosteroids and cytotoxic agents.
Copyright © 2014. Published by Elsevier Masson SAS.
Similar articles
-
[Childhood onset systemic lupus erythematosus: how does it must be treated in 2010?].Arch Pediatr. 2010 Jun;17(6):632-3. doi: 10.1016/S0929-693X(10)70033-6. Arch Pediatr. 2010. PMID: 20654815 French. No abstract available.
-
Recent news in the treatment of lupus nephritis.Minerva Med. 2012 Aug;103(4):235-51. Minerva Med. 2012. PMID: 22805617 Review.
-
Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.Mod Rheumatol. 2015 Mar;25(2):210-4. doi: 10.3109/14397595.2014.950810. Epub 2014 Aug 27. Mod Rheumatol. 2015. PMID: 25159157
-
[Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].Dtsch Med Wochenschr. 2006 Oct 13;131(41):2266-9. doi: 10.1055/s-2006-951361. Dtsch Med Wochenschr. 2006. PMID: 17036267 German.
-
Systemic lupus erythematosus.Lancet. 2007 Feb 17;369(9561):587-96. doi: 10.1016/S0140-6736(07)60279-7. Lancet. 2007. PMID: 17307106 Review.
Cited by
-
Females uniquely vulnerable to alcohol-induced neurotoxicity show altered glucocorticoid signaling.Brain Res. 2015 Mar 19;1601:102-16. doi: 10.1016/j.brainres.2015.01.002. Epub 2015 Jan 16. Brain Res. 2015. PMID: 25601008 Free PMC article.
-
Prevalence of the Oral Corticosteroid Exposure and Excessive Use in Patients with Inflammatory Bowel Disease: Data from Four French Referral Centers of the International DICE Study.J Clin Med. 2024 Apr 30;13(9):2652. doi: 10.3390/jcm13092652. J Clin Med. 2024. PMID: 38731182 Free PMC article.
-
Update on Biologic Therapies for Systemic Lupus Erythematosus.Curr Rheumatol Rep. 2016 Jul;18(7):44. doi: 10.1007/s11926-016-0589-5. Curr Rheumatol Rep. 2016. PMID: 27299782 Review.
-
First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study.Rheumatol Ther. 2016 Dec;3(2):271-290. doi: 10.1007/s40744-016-0047-x. Epub 2016 Nov 1. Rheumatol Ther. 2016. PMID: 27804088 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous